ME/CFS after COVID-19 vs. before the pandemic
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study looks at how the brain's protective barrier and immune system work in people with ME/CFS, comparing those who got sick before the COVID-19 pandemic to those who developed ME/CFS after a COVID-19 infection. It aims to understand why some people have lasting brain fog, fatigue, and other neuropsychiatric symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 70 years old.
- You need at least an 8th-grade education level.
- Your ME/CFS symptoms started either before July 2019 or after a COVID-19 infection.
- You have severe fatigue for at least 6 months that gets worse after activity, unrefreshing sleep, and either trouble thinking or dizziness when standing.
- You must have at least one neuropsychiatric symptom, like brain fog, anxiety, depression, or headaches.
- You cannot have a serious mental illness, neurological disorder, metal in your body, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses brain scans to understand why people with long COVID feel very tired or have trouble thinking clearly. It could help find new treatments for these symptoms.
This study looks for signs of leftover SARS-CoV-2 virus in people who have fully recovered from COVID-19, including those with ongoing neurological symptoms (like brain fog, fatigue, or nerve pain). It aims to understand why some people have long-lasting symptoms after infection.
This study looks at how chronic infections and inflammation affect people with ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome) compared to healthy people. Researchers want to understand what causes symptoms and find better ways to help.
This study observes how a blood-cleaning treatment called immunoadsorption works in patients with ME/CFS (severe fatigue condition) who have specific immune markers. Researchers will track whether this treatment helps reduce symptoms and improve daily functioning.
This study looks at how post-exertional malaise (PEM) affects people with ME/CFS. It aims to understand the condition better and find new ways to help.
This study tests whether acupuncture can help improve thinking and memory problems in people with long-term fatigue after COVID-19 (often called ME/CFS). If you have had fatigue for at least 6 months after a COVID-19 infection and meet specific criteria, this trial may offer a non-drug treatment option.
Hear when a new Chronic Fatigue Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.